UK health cost body backs Novartis asthma drug in fresh U-turn – Yahoo! News (blog)


Yahoo! News (blog)

UK health cost body backs Novartis asthma drug in fresh U-turn
Yahoo! News (blog)
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health
U-turn As Asthma Drug Gets Go-aheadThe Australian
NICE U-turn over asthma drug omalizumabGP online

all 3 news articles »

View full post on asthma – Google News

UK health cost body backs Novartis asthma drug in fresh U-turn – Reuters

UK health cost body backs Novartis asthma drug in fresh U-turn
Reuters
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health
NICE U-turn over asthma drug omalizumabGP online

all 2 news articles »

View full post on asthma – Google News

Drug to Treat Asthma Could Relieve Hives Patients of a Chronic Itch, Study Says – New York Times


NBCNews.com (blog)

Drug to Treat Asthma Could Relieve Hives Patients of a Chronic Itch, Study Says
New York Times
An asthma drug has shown promise in relieving itchiness for patients with chronic hives who do not get relief from traditional antihistamine treatment. The drug, omalizumab, known by its brand name, Xolair, is a monoclonal antibody approved to treat
Asthma drug can ease agony of constant itch, tooNBCNews.com (blog)
Asthma Drug Found Highly Effective in Treating Chronic, Severe Hives and ItchScience Daily (press release)
Asthma Drug Curbs Chronic HivesMedPage Today
The Inquisitr –Doctor Tipster –Medscape
all 11 news articles »

View full post on asthma – Google News